Dec 242015
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– UK, London – Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK), the FTSE 100 pharmaceuticals company, is today announcing an update on its agreement to acquire Roxane Laboratories Inc. and Boehringer Ingelheim Roxane Inc. from Boehringer Ingelheim (“BI”).

New Director Nomination Right

Hikma has agreed that BI may nominate one non-executive director to Hikma’s Board of Directors from time to time for so long as BI has a shareholding in Hikma representing 10% or more of Hikma’s issued share capital.… => more

Hikma Pharmaceuticals announces upcoming appointment of Dr Jochen Gann to its Board of Directors

From:: Hikma Pharmaceuticals announces upcoming appointment of Dr Jochen Gann to its Board of Directors

 Posted by at 10:58 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: